Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02732938
Title Ph1b/2 Study of PF-04136309 in Combination With Gem/Nab-P in First-line Metastatic Pancreatic Patients (CCR2i)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer

pancreatic ductal adenocarcinoma


Gemcitabine + Nab-paclitaxel + PF-04136309

Age Groups: adult
Covered Countries USA

No variant requirements are available.